Studies have shown that people with high levels of omega-3s are better protected against serious COVID-19 infections.

Published Date: 02 Mar 2023

A study recently published in the American Journal of Clinical Nutrition (AJCN) investigated the role of omega-3 fatty acids, specifically EPA and DHA, and whether they can prevent poor and/or negative weight loss. .

Read Full News

Latest News

Ebola Response Making Progress in Congo, but Outbreak 'far From Over,' WHO Says

The World Health Organization said on Wednesday there were encouraging signs measures to contain an Ebola epidemic ⁠in Democratic Republic of Congo were gaining ground,...

Two More HIV Cure Cases Reported at AIDS 2026

One of the cases includes the first successful HIV cure with a mixed HIV tropism, suggesting cure may be possible in patients without the known mutation that confers HIV-1 resistance.

Aid Cuts Hit Disease Prevention Harder Than Treatment

Efforts to prevent people from getting AIDS, malaria and tuberculosis were hit harder by global aid cuts last year ⁠than services to treat existing patients, according to the Global Fund head.

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America

U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American ⁠Health Organization to widen access to its HIV prevention drug.

Diagnostic Challenges and Clinical Insights of Neurosyphilis

Neurosyphilis, a serious complication of untreated syphilis, can cause irreversible sequelae, including vision loss, hearing loss, and paralysis.

EU Advances Legislation to Avert Drug Shortages

New measures call for stronger shortage monitoring, earlier disruption alerts, and greater cooperation among EU countries to protect supplies of medicines with few alternatives.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Todays Updates

First-Line Combo Therapies Best Chemo Alone in NSCLC Trials

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

3D Mammography Improves Long-Term Cancer Risk Prediction

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Latest News

The World Health Organization said on Wednesday there were encouraging signs measures to contain an Ebola epidemic ⁠in Democratic Republic of Congo were gaining ground,...

One of the cases includes the first successful HIV cure with a mixed HIV tropism, suggesting cure may be possible in patients without the known mutation that confers HIV-1 resistance.

Efforts to prevent people from getting AIDS, malaria and tuberculosis were hit harder by global aid cuts last year ⁠than services to treat existing patients, according to the Global Fund head.

U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American ⁠Health Organization to widen access to its HIV prevention drug.

Neurosyphilis, a serious complication of untreated syphilis, can cause irreversible sequelae, including vision loss, hearing loss, and paralysis.

New measures call for stronger shortage monitoring, earlier disruption alerts, and greater cooperation among EU countries to protect supplies of medicines with few alternatives.

News All Time

As Schools Re-open, Congo Drops Remote Learning Plan in Ebola Red Zone

Schools reopened this week in areas of Democratic Republic of Congo hardest hit by Ebola, after authorities decided the risk of transmission ⁠was outweighed by the risk of...

WHO's Tedros Says Ebola Response Must Be Scaled Up to Tackle Congo Outbreak

The head of the World Health Organization on Wednesday said the Ebola response needs to be scaled up to tackle the outbreak in the Democratic Republic ⁠of Congo, with...

Health Officials Turn to Mobile-phone Data to Track Ebola Spread in Congo

Health officials battling the Ebola outbreak in eastern Democratic Republic of Congo are using anonymised mobile-phone data to map population movements and identify areas...

Gepotidacin as Effective as Standard Therapy for Gonorrhea

Nucleic acid amplification test-confirmed success rates for urogenital gonorrhea are high and similar to those of oral gepotidacin and ceftriaxone plus azithromycin, a phase 3 trial shows.

GSK to Advance MRNA Flu Vaccine to Late-stage Trial

(Corrects paragraph 4 to clarify that GSK plans to start more than 20, ⁠not 25, late-stage trials in 2026)

UK Pledges Additional £50 Million to Help Contain Ebola Outbreak in Congo

Britain said on Tuesday it would provide more than £50 ⁠million ($67.56 million) in new funding to support efforts to contain an ⁠Ebola outbreak in the Democratic Republic...

Congo's Ebola Outbreak Kills More Than 3,000, Government Figures Show

The number of deaths in Democratic Republic of Congo's Ebola outbreak has surpassed 3,000, government ⁠data showed on Wednesday, as the country's worst-ever epidemic...

USDA Cyclospora Research Projects Shelved Amid Funding Cuts and Relocations, Politico Reports

The Trump administration is shuttering two of the three U.S. Department of Agriculture research projects studying cyclospora, ⁠a foodborne parasite that has sickened...

Measles Cases in Pennsylvania Rise to 460 Amid Ongoing Outbreak

Pennsylvania's health department said on Friday the confirmed number of cases linked to a measles ⁠outbreak has reached 460 this year, an increase of 36 over its update two...

More Than 6,000 People Infected With Ebola in Congo, Government Figures Show

The number of confirmed Ebola ⁠cases in the Democratic Republic of Congo has ⁠passed the 6,000 mark, government data ⁠showed on Monday.

US Widens Lettuce-related Cyclosporiasis Probe to 20 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce ⁠from central Mexico after detecting cases in three additional...

US FDA Approves Updated COVID Vaccines for 2026-27 Season

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi ⁠and Pfizer-BioNTech's updated COVID vaccines, the companies said on Thursday, ⁠after an advisory...

HIV Resistance Assay Offers Quick, Low-Cost Results for RTs

The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including dolutegravir, a first-line drug with growing resistance.

Congo Starts Ebola Vaccinations for Health Workers

Democratic Republic of Congo on Thursday began vaccinating frontline health workers with a vaccine ⁠approved for a different Ebola species, as authorities seek to contain...

Dolutegravir ART Receives FDA Approval for Newborns With HIV

As the first second-generation INSTI approved for newborns with HIV, this approval allows for a simpler, more robust antiretroviral therapy regimen than existing standard of care.

Groups Work to Save Lives as Ebola Spreads in Central Africa

Even though the virus has faded from US headlines, key organizations are still at work providing medical care and training to counter the spread of the disease.

Recommended News For You

Treating advanced prostate cancer

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

Dissociative identity disorder: method or fact?

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

The use of biomarkers in the treatment of breast lumps is at a crossroads.

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

Recommended Articles For You

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

Introduction to Immune Thrombocytopenic Purpura 

Extracellular Vesicle Markers of Platelet Activation: Clinical Relevance and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New guidelines for radiation therapy for HPV-associated head and neck cancer

2.

Cancer mortality continuing to decline, says report

3.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

4.

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

5.

Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

1.

Different Types of Blood Dyscrasias 

2.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

3.

Lymphomatoid Papulosis: What You Need to Know

4.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

5.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Clinical Insights in Oncology

2.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Navigating the Complexities of Ph Negative ALL - Part XI

5.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot